[ Price : $8.95]
FDA issues a clinical hold on VYNE Therapeutics Phase 1b study evaluating VYN202 for treating moderate-to-severe plaque psoriasis ...[ Price : $8.95]
HHS secretary Robert F. Kennedy Jr. vows to restore FDAs and other health agencies Freedom of Information Act (FOIA) offices that ...[ Price : $8.95]
FDA grants Orchestra BioMed a breakthrough device designation for its atrioventricular interval modulation therapy that uses a pac...[ Price : $8.95]
A Northern Texas federal judge denies a preliminary injunction sought by Outsourcing Facilities Association to delay FDA enforceme...[ Price : $8.95]
FDA awards BrainChild Bio a breakthrough therapy designation for its investigational CAR T-cell therapy, BCB-276, for treating a r...[ Price : $8.95]
Amneal Pharmaceutical recalls two lots of ropivacaine hydrochloride injection USP, 500 mg/100 mL, infusion bags because the produc...[ Price : $8.95]
FDA alerts health care providers about reports of falsely elevated results associated with ASP Globals RAM Scientific SAFE-T-FILL ...[ Price : $8.95]
FDA warns Houston, TX-based Empower Pharma about multiple violations in its production of unapproved and misbranded compounded dru...